Jonathan Lu
University of Connecticut(US)
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Adipokines, Inflammation, and Metabolic Diseases, Antioxidant Activity and Oxidative Stress, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription(2003)155 cited
- → Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis(2015)133 cited
- → Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1(2009)132 cited
- → Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1(2007)84 cited
- → Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation(2013)79 cited
- → Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation(2007)72 cited
- → Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application(2004)72 cited
- → Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction(2013)56 cited
- → Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo(2018)55 cited
- → Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor(2013)45 cited